Andrew A Krakauer
CIK 1302168 · CEO · last filed 2026-05-19
Andrew A Krakauer is a CEO who has filed 60 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for TFX, was dated May 19, 2026. Across all open-market trades the lifetime net is −$8.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.08M
2
60
-$8.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TFX | Director | 8,308 | $130.48 | $1.08M | $660.0K | 13 | 2026-05-19 |
| CANTEL MEDICAL CORP (CMN) Delisted | CEO | 143,341 | — | — | -$9.57M | 47 | 2015-12-31 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-19 | TFX | Grant (A) | +1,090 | $0 | EDGAR |
| 2025-08-07 | TFX | Buy (P) | +1,000 | $115.2K | EDGAR |
| 2025-05-13 | TFX | Grant (A) | +1,051 | $0 | EDGAR |
| 2024-05-09 | TFX | Grant (A) | +649 | $0 | EDGAR |
| 2023-05-11 | TFX | Grant (A) | +527 | $0 | EDGAR |
| 2022-05-04 | TFX | Grant (A) | +399 | $0 | EDGAR |
| 2021-12-02 | TFX | Buy (P) | +1,000 | $307.2K | EDGAR |
| 2021-05-06 | TFX | Grant (A) | +300 | $0 | EDGAR |
| 2020-05-07 | TFX | Grant (A) | +383 | $0 | EDGAR |
| 2019-05-08 | TFX | Grant (A) | +347 | $0 | EDGAR |